💡 Did you know? #MedsPaL is a free resource providing crucial information on the intellectual property status of patented essential medicines in LMICs, patent information on COVID-19 and Mpox vaccines, and long-acting platform technologies worldwide. 👉 www.medspal.org

At #ASCO26, the conversation is rightly focused on #innovation. @medicinespatentpool.org is a partner of choice to explore how innovation can reach patients in LMICs in a sustainable way while generating #value for patent holders.

Demonstrating continued and sustained impact for people in low- and middle-income countries (LMICs), MPP today publishes its 2025 annual report, From Innovation to Access. 👉 Download MPP's 2025 Annual Report: medicinespatentpool.org/news-publica...

At #WHA79, MPP welcomed the renewed commitment to accelerate progress towards malaria elimination. Public health-oriented #voluntarylicensing helps expand access to innovative medicines by reducing delays, lowering costs, and strengthening supply security. 👉 medicinespatentpool.org/news-publica...

At #WHA79, MPP highlighted the role of non-exclusive licensing and technology transfer in advancing the equity objectives of the @who.int Pandemic Agreement. medicinespatentpool.org/news-publica... #GlobalHealth #PandemicPreparedness #HealthEquity

Today at #WHA79, MPP and Roche celebrated the signing of a public health-oriented voluntary licence agreement for baloxavir marboxil, an #influenza antiviral treatment recommended by @who.int. Read the announcement: bit.ly/4wwZsW1 @unitaid.bsky.social @drduneton.bsky.social

At #INTEREST2026 in Dar es Salaam earlier this week, @sebmoringva.bsky.social (MPP) unpacked what the new @who.int HIV treatment recommendations mean in practice: TAF-based regimens, DTG+3TC simplification, and long-acting CAB+RPV, and how access could be enhanced in many settings. #HIV

🚨 BREAKING: MPP today launches ambitious five-year strategy to further catalyse access to essential health products and technologies in low- and middle-income countries (LMICs). Read more about MPP's Strategy 2026-2030: https://medicinespatentpool.org/who-we-are/strategy

Attending INTEREST 2026 in Tanzania? 🇹🇿 Join us on 14 May 14 2026 for Session 12: Health Systems: Financing and Implementation Science. 🕐 1:45 PM (Eastern Africa Time (EAT) 🎤 “Access to medicines in a new era” - @sebmoringva.bsky.social 👉 interestworkshop.org/sessions/ses...

🌍 During the 79th #WHA79 in Geneva, MPP will engage both in the formal proceedings of the Assembly and in a number of side events and partner-led discussions. 📍See the full programme: medicinespatentpool.org/news-publica...

🌍 At the #AfricaForward, MPP joined the panel “Health & Pharma: Building Competitive #African #Pharmaceutical Capacity.” 💬 The discussion highlighted key drivers of Africa’s pharmaceutical ecosystem: regulation, predictable markets, local production, technology transfer, and regional partnerships.

🚨 #AFRAVIH2026 – Retrouvez-nous à Lausanne ! 🇨🇭 📍 Stand 6 – Aujourd’hui et demain 👉 Échangez avec nos experts et découvrez nos actions pour améliorer l’accès aux traitements. 👉 medicinespatentpool.org/fr/news-publ... @sebmoringva.bsky.social

📢 Rejoignez-nous à #AFRAVIH2026 pour le symposium MPP– @unitaid.bsky.social! 🗓 Lundi 4 mai | 14h30–15h30 📍 Salle 3 – Moritz B, Lausanne 🇨🇭 👉 Un enjeu clé pour une réponse au #VIH plus diversifiée, plus adaptée et centrée sur les personnes. 👉 medicinespatentpool.org/fr/news-publ...

📢 À ne pas manquer à #AFRAVIH2026! Participez à la session plénière 2 : 🗓 Mercredi 6 mai | À partir de 08h30 📍 Salle 1 – Théâtre, Centre de congrès, Lausanne, Suisse 👉 medicinespatentpool.org/fr/news-publ... #VIH #PrEP #SantéMondiale #AccèsAuxSoins #AFRAVIH #VIH #SantéPublique

LAPaL updates: New drugs (full pharmacological data): - Benzathine benzylpenicillin LA compounds + regulatory info - Depulfavirine nanosphere LAI + clinical trial - Bictegravir PLGA nanoformulation + preclinical Updated: - Risperidone LAI - regulatory status www.liverpool.ac.uk/celt-global-...

📢 Rejoignez-nous à #AFRAVIH2026 pour le symposium MPP– @unitaid.bsky.social! 🗓 Lundi 4 mai | 14h30–15h30 📍 Salle 3 – Moritz B, Lausanne 🇨🇭 👉 Un enjeu clé pour une réponse au #VIH plus diversifiée, plus adaptée et centrée sur les personnes. 👉 medicinespatentpool.org/fr/news-publ...

L’équipe de @medicinespatentpool.org participera à #AFRAVIH2026 à Lausanne🇨🇭 À partir du 4 mai, retrouvez-nous aux côtés d’acteurs engagés dans la lutte contre le #VIH et d’autres infections virales. 👉 medicinespatentpool.org/news-publica... @sebmoringva.bsky.social

🌍 At #WHS2026, Mila Maistat on progress in #hepatitis access: “Once seen as unattainable due to high prices, elimination is now within reach thanks to affordable, licensed treatments. Governments’ commitment is key to scale up access and reach everyone in need.”

🌍 World #Hepatitis Summit 2026 Today at #WHS2026, Charles Gore challenged how we frame the hepatitis #elimination debate: “If you ask ‘Can we achieve elimination?’ you mainly see the problems. If you ask ‘How do we achieve elimination?’ you start seeing the solutions.” @worldhepalliance.bsky.social

📣 Call for Applications – Technical Training for IVD Manufacturers in Africa The @who.int and @medicinespatentpool.org are inviting diagnostic manufacturers to apply for a 4-day, in-person training on #technologytransfer. 🇰🇪 Nairobi, Kenya 📅 26–29 May 2026 👉 medicinespatentpool.org/news-publica...

Ahead of #WHS2026, Charles Gore spoke at the @who.int Global Forum on viral #hepatitis elimination, warning that HBV deaths are rising, treatment gaps persist, and advocacy still lags. #CHAI stressed that strong partnerships and urgent scale-up of diagnosis and treatment are key to elimination.

This #WorldIPDay, we’re pleased to share updates on MPP’s open‑access tools supporting transparency in the #GlobalHealth IP landscape. 🎥 New #MedsPaL tutorial ▶️ bit.ly/4tzYA0E 🎙️interview with @sebmoringva.bsky.social ▶️ bit.ly/4mUdZqn #AccessToMedicines #OpenAccess

🌍 On #WorldIPDay, here are MPP’s open‑access tools supporting transparency in the #globalhealth IP landscape. 🔎 #MedsPaL: patent & licence data on essential meds, vaccines & long‑acting tech 👉 medspal.org 🧬 #LAPaL: expert‑curated intelligence on LA therapeutics 👉 lapal.ch

Ahead of #WorldIPDay, MPP is highlighting its MedsPaL database. 🌍 Read our interview with @sebmoringva.bsky.social in which he describes #MedsPaL's unique benefits, and how it helps him and colleagues to navigate the global access landscape. 👉 medicinespatentpool.org/story-post/m...

🦟 #Malaria is preventable and curable, yet it continues to take hundreds of thousands of lives every year, mostly in LMICs. 🌍 Ahead of #WorldMalariaDay, MPP reaffirms its commitment to supporting access to life-saving malaria prevention and treatment tools. 👉 medicinespatentpool.org

🎥 Ahead of #WorldIntellectualPropertyDay, we’re pleased to launch Tutorial #3, spotlighting the advanced filters in #MedsPaL 🌍💊 👉 Check out the tutorial: www.youtube.com/watch?v=oEh-... 👉 Check out our video #tutorial series: www.youtube.com/playlist?lis... 🔗 www.medspal.org #WorldIPDay

🌍 MPP is hiring! 💊 Drug Product Expert (Vacancy) 📅 Apply by 20 April 2026 💻 Digital Optimisation and Process Automation Consultancy (Request for proposals) 📅 Apply by 20 April 2026 👉 medicinespatentpool.org/who-we-are/c... #JobOpportunities #GlobalHealth #AccessToMedicines

Today is the #IDMHR2026 🤰🌍, a reminder that too many women still die from childbirth complications. Midwife Mame Laitite Diallo Diouf 🇸🇳 shares how greater access to HSC could save lives. Our agreement with Ferring regarding HSC: https://medicinespatentpool.org/licence-post/heat-stable-carbetocin

✨ Turning innovation into access ✨ 🌍 By working in #partnership with civil society, industry, governments and global health actors, MPP turns innovation into #affordable access to medicines in LMICs, because where you live should never define your access to care.💙 👉 medicinespatentpool.org

📣 Call for Applications – Technical Training for IVD Manufacturers in Africa The @who.int and @medicinespatentpool.org are inviting diagnostic manufacturers to apply for a 4-day, in-person training on #technologytransfer. 🇰🇪 Nairobi, Kenya 📅 26–29 May 2026 👉 medicinespatentpool.org/news-publica...

Recently LAPaL updates New drug delivery technologies: Multi-Arm Polymer Conjugated Immunotherapies Plexis Long-acting Injectable Technology New drugs: GS-3242 Acoziborole And we've updated: Ulonivirine VH-499 VH-148 Alimatravir GS-3107 www.liverpool.ac.uk/celt-global-... @medicinespatentpool.org

🌍 MPP is hiring! 💊 Drug Product Expert (Vacancy) 📅 Apply by 20 April 2026 💻 Digital Optimisation and Process Automation Consultancy (Request for proposals) 📅 Apply by 20 April 2026 👉 medicinespatentpool.org/who-we-are/c... #JobOpportunities #GlobalHealth #AccessToMedicines

MPP's Mila Maistat helped launch the @who.int HBV & HCV Guidance, stressing that #viralhepatitis, #diagnostics, and affordable treatments via @medicinespatentpool.org #licensing are vital.

🛎️ Starting in 1 hour Join MPP a for a 90-minute information session on our #Strategy 2026–2030. Discover our five-year #goals and hear from experts during a panel discussion on key strategic #priorities! ⏳ Last chance to register: us06web.zoom.us/webinar/regi...

✨ Advancing access, Together ✨ We’re working to ensure people, especially in LMICs, can access innovative, effective, and affordable medicines and health technologies. Through collaboration, licensing, and tech transfer, we’re helping make equitable healthcare a global reality.💙 👉 lnkd.in/dJvmU_V

🚀 2 days away - 26 March | 14:00 CET ⏳ There’s still time to join the @medicinespatentpool.org for a 90-minute dedicated information session on our Strategy 2026–2030. Learn about our five-year goals and join a panel discussion on our strategic priorities. us06web.zoom.us/webinar/regi...

This #WorldTBDay, we spotlight long-acting injectables for latent TB - a single injection instead of months of pills. Through the LONGEVITY project, MPP’s partnership with Tandem Nano aims to simplify treatment, reduce stigma, and improve adherence. 👉 medicinespatentpool.org/story-post/l...

🌍 Marking #WorldTBDay with global collaboration! MPP highlights a meaningful meeting in Hanoi 🇻🇳 with Oanh Khuat (SCDI Vietnam), recently honored with France’s National Medal of Merit for her work supporting vulnerable communities and advancing HIV/AIDS and health policy. 🎦 youtu.be/ZtSwb-FsRCQ?...

#WorldTBDay highlights that TB is preventable and curable, yet still kills over a million people yearly, with drug-resistant TB on the rise. Progress continues, but targets remain unmet. MPP helps expand access to treatments and accelerate new therapies. 👉 medicinespatentpool.org/progress-ach...

MPP's Mila Maistat delivered a statement at the 6th meeting of the Intergovernmental Working Group on the @who.int #PandemicAgreement, highlighting the crucial role of non‑exclusive licensing and technology transfer for equitable pandemic preparedness. 🔗 medicinespatentpool.org/news-publica...

📅 Save the Date | 26 March | 14:00 CET As #MPP prepares to launch its Strategy 2026–2030 in May, join us for an information session outlining our five-year ambition, goals and targets. 🖥️ 90 min webinar + panel discussion Register: us06web.zoom.us/webinar/regi... #GlobalHealth #AccessToMedicines

✨ New logo reveal ✨ Since 2010, MPP has worked to expand #access to essential medicines and health technologies worldwide. A new look, the same unwavering commitment to equity and partnership. 👉 medicinespatentpool.org/news-publica... @unitaid.bsky.social

We’re excited to welcome Fitsum Alemayehu to the MPP’s Community Advisory Panel! He will bring his expertise in #pandemicpreparedness and community engagement to help ensure community perspectives guide our work for equitable access to health technologies. 👉 medicinespatentpool.org/who-we-are/g...

Proud to partner with @unitaid.bsky.social to help ensure health innovations reach those who need them most. At MPP, we contribute to expanding access to innovative medicines and other health technologies through public health‑oriented voluntary licensing and technology transfer. Have a read👇

📅 Save the Date | 26 March | 14:00 CET As #MPP prepares to launch its Strategy 2026–2030 in May, join us for an information session outlining our five-year ambition, goals and targets. 🖥️ 90 min webinar + panel discussion Register: us06web.zoom.us/webinar/regi... #GlobalHealth #AccessToMedicines

On #IWD2026, we celebrate women driving change in #GlobalHealth from labs to communities. ✅Huong Ngo Thu of Polyvac is advancing #mRNA vaccines in #Vietnam 🔗 bit.ly/4d8VP10 ✅In #Uganda, Gertrude Nakigudde supports women, pushing for earlier diagnosis, access to treatment of #cancer 🔗 bit.ly/40OTqBd

For Ogweno Stephen, it’s personal, growing up in Kenya 🇰🇪, obesity was seen as prosperity, but it often meant health issues, stigma, and isolation. After #WorldObesityDay, the message is clear: LMICs can’t ignore adolescent obesity. 👉 medicinespatentpool.org/story-post/w...

For #WorldObesityDay, Nomathemba Chandiwana of the Desmond Tutu Health Foundation calls for action on barriers to care. #Obesity is rising worldwide 🌍, and the World Obesity Federation urges an end to stigma and equitable access to care ✨. 👉 medicinespatentpool.org/story-post/w...

Advances in cardiometabolic health bring hope for #obesity and type 2 diabetes, but access gaps remain 🌍 At MPP, we promote equitable #access through #voluntary #licensing. On #WorldObesityDay 🌱, we stand for healthier lives ❤️ 👉 www.worldobesityday.org #WOD2026 @worldobesity.bsky.social

Ahead of #WorldObesityDay 🌍, Ogweno Stephen 🇰🇪 highlights the rising childhood obesity crisis in LMICs. From facing obesity stigma in rural #Kenya, he now champions support for young people 🤝 and urges action on rising obesity, #diabetes, and #heart disease. @worldobesity.bsky.social